Results 191 to 200 of about 205,038 (298)

Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: an overview [PDF]

, 2012
Ghina Ghazeeri, Anwar H. Nassar, Zeina M. H. Younes, Johnny Awwad   +3 more
openalex   +1 more source

Nephrological perspectives on the underutilization of SGLT2is in heart failure and chronic kidney disease

ESC Heart Failure, Volume 12, Issue 2, Page 1490-1491, April 2025.
Özant Helvacı, Ömer Faruk Akçay, Emre Yaşar, Ülver Derici, Galip Güz   +4 more
wiley   +1 more source

Cost-effectiveness of metformin in the prevention of Type 2 diabetes mellitus: A systematic review

Nguyễn Thị Thu Thủy, To Hue Nghi, Trần Ngọc Thanh, Houng Duong, Nguyen Dao Nhat Huy   +4 more
openalex   +1 more source

The protective role of metformin against severe dengue disease in patients with type 2 diabetes mellitus: a preliminary report in Mexico. [PDF]

World J Emerg Med
Manuel Reyes-Ruiz J, María Del Ángel R, Noe Farfan-Morales C, Daniel Cordero-Rivera C, Adrián De Jesús-González L, Noé Palacios-Rápalo S, Fidel Osuna-Ramos J, Martínez-Mier G, Jhosimar Sánchez-Jiménez N, Bernal-Dolores V, Arturo García-Grajales S, Sandoval-Guzmán I, Samantha González-Medel K.   +12 more
europepmc   +1 more source

Antidiabetic Effects of Gymnema sylvestre and Metformin Co-Therapy in a Type 2 Diabetic Rat Model

Ajay Kodiyatar, Akhilesh Mishra, Megh Singh Dhakad, Vandana Roy, Niket Rai   +4 more
openalex   +1 more source

Metformin protects against cyclophosphamide-induced ovarian fibrosis by MIF/CD74-mediated macrophage polarization. [PDF]

J Transl Med
Nie P, Yao B, Zhang Z, Li J, Wang M, Lash GE, Guo B, Li P.   +7 more
europepmc   +1 more source

Effects of rosiglitazone and metformin on pancreatic beta cell gene expression [PDF]

, 2006
Hugh H. Richardson, Susan C. Campbell, Stephen A. Smith, Wendy M. Macfarlane   +3 more
openalex   +1 more source

Metformin: historical overview

Diabetologia, 2017
C. Bailey
semanticscholar   +1 more source

Targeting aerobic glycolysis combats tyrosine kinase inhibitor resistance of hepatocellular carcinoma

International Journal of Cancer, EarlyView.
Abstract Hepatocellular carcinoma (HCC) represents the predominant form of primary liver cancer and is frequently identified at a late stage, necessitating systemic therapy. However, resistance to first‐line tyrosine kinase inhibitor therapies, such as sorafenib and lenvatinib, remains a significant clinical challenge.
Longtao Zhao, Junjie Cheng, Yiming Zheng, Jing Wu, Jia Fan, Haixiang Sun, Chao Gao   +6 more
wiley   +1 more source

Foetal Metformin Exposure, Childhood Adiposity and Future Cardiovascular Risk: Can We Connect the Dots? [PDF]

touchREV Endocrinol
Thakkar S, Bhattacharya S, Nagendra L, Kapoor N, Dutta D, Kalra S.   +5 more
europepmc   +1 more source